Regulations.gov document
Testing for Biotin Interference in In Vitro Diagnostic Devices; Guidance for Industry…
Notice · FDA-2019-D-1876 · posted Oct 16, 2020
Key facts
| Document ID | FDA-2019-D-1876-0011 |
|---|---|
| Title | Testing for Biotin Interference in In Vitro Diagnostic Devices; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-1876 |
| Posted | Oct 16, 2020 |
| Federal Register citation | 85 FR 65817 |
| FR document number | 2020-22926 |
| Comment period opens | Oct 16, 2020 |
| Effective date | Oct 16, 2020 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: